In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster session 4 Tuesday 08:30 - 12:30: Basic Science: Ischemic preconditioning
Session

Event : Heart Failure 2015

Topic : Other

  • Session type : Poster Session
  • Date : 26 May 2015
  • Time : 08:30 - 12:30

11 presentations in this session

Characterization of the effects of novel ATP-sensitive potassium channel openers in isolated rat heart mitochondria

Event : Heart Failure 2015

  • Session : Basic Science: Ischemic preconditioning
  • Speaker : OM Duicu (Timisoara,RO)

Exenatide prevents morphological and structural injury of mitochondria in ischemia-reperfusion injury

Event : Heart Failure 2015

  • Session : Basic Science: Ischemic preconditioning
  • Speaker : W Kim (Seoul,KR)

An impact of remote ischemic preconditioning on ischemia-reperfusion injury in the isolated diabetic rat heart

Event : Heart Failure 2015

  • Session : Basic Science: Ischemic preconditioning
  • Speaker : M Murarikova (Bratislava,SK)

Inhibition of H2S formation from L-cysteine provides cardioprotection against ischemia/reperfusion in rats

Event : Heart Failure 2015

  • Session : Basic Science: Ischemic preconditioning
  • Speaker : Y Goshovska (Kyiv,UA)

Role of inflammasomes and its regulation in the myocardium after ischemia and reperfusion

Event : Heart Failure 2015

  • Session : Basic Science: Ischemic preconditioning
  • Speaker : L Varela Perez (Seville,ES)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are